Learn More
Medchemexpress LLC Pulrodemstat benzenesulfonate | 2097523-60-7 | 99.6% | 50 MG

Supplier: Medchemexpress LLC HY129388B50MG
Pulrodemstat benzenesulfonate is a potent, selective, reversible, and orally active inhibitor of lysine specific demethylase-1 (LSD1) with an IC50 of 0.25 nM. It induces differentiation in acute myeloid leukemia (AML) and small cell lung cancer (SCLC) cells, demonstrating potent anticancer activity.
- Potent, selective, reversible, and orally active LSD1 inhibitor
- Less enzymatic inhibition against LSD2, MAO-A, and MAO-B
- Induces differentiation in AML and SCLC cells
- Demonstrates potent anticancer activity
- Shows potent induction of CD11b in THP-1 cell line
- Exhibits antiproliferative activity in AML kasumi-1 cells
- Suppression of GRP observed in a dose-dependent manner
- Potent antiproliferative activity in SCLC cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.